Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Complications

By Mayo Clinic staff

Living with cancer newsletter

Subscribe to our Living with cancer newsletter to stay up to date on cancer topics.

Hairy cell leukemia progresses very slowly and sometimes remains stable for many years. For this reason, few complications of the disease occur. However, untreated hairy cell leukemia that progresses may crowd out healthy blood cells, leading to serious complications, such as:

  • Infections. Low white blood cell counts put you at risk of infections that your body might otherwise fight off.
  • Bleeding. Low platelet counts make it hard for your body to stop bleeding once it starts. If you have a mildly low platelet count, you might notice that you bruise more easily. Very low platelet counts can cause spontaneous bleeding from the nose or gums.
  • Anemia. A low red blood cell count means fewer cells are available to carry oxygen throughout your body. This is called anemia. Anemia causes fatigue.

Increased risk of second cancers
Some studies have found that people with hairy cell leukemia may have an increased risk of developing a second type of cancer. It isn't clear whether this risk is due to hairy cell leukemia's effect on the body or if the risk comes from the medications used to treat hairy cell leukemia. Second cancers found in people treated for hairy cell leukemia include Hodgkin's disease and non-Hodgkin's lymphoma, among others.

References
  1. Tallman MS, et al. Hairy cell leukemia. In: Abeloff MD. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa.: Churchill Livingstone; 2008:2309.
  2. Zakarija A, et al. Hairy cell leukemia. In: Hoffman R, et al. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa.: Churchill Livingstone; 2008. http://www.mdconsult.com/book/player/book.do?method=display&type=aboutPage&decorator=header&eid=4-u1.0-B978-0-443-06715-0..X5001-8--TOP&isbn=978-0-443-06715-0&uniq=177554631. Accessed Jan. 7, 2010.
  3. Saven A. Hairy cell leukemia. In: Lichtman MA, et al. Williams Hematology. 7th ed. New York, N.Y.: McGraw-Hill; 2008. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=69. Accessed Jan. 7, 2010.
  4. Hairy cell leukemia treatment (PDQ): Patient version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/hairy-cell-leukemia/patient/allpages/print. Accessed Jan. 7, 2010.
  5. Hairy cell leukemia treatment (PDQ): Health professional version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/hairy-cell-leukemia/healthprofessional/allpages/print. Accessed Jan. 7, 2010.
  6. Rituxan (prescribing information). South San Francisco, Calif.: Genentech Inc.; 2009. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103705s5299lbl.pdf. Accessed Jan. 7, 2010.
  7. Integrative medicine & complementary and alternative therapies as part of blood cancer care. The Leukemia & Lymphoma Society. http://www.leukemia-lymphoma.org/attachments/National/br_1150734030.pdf. Jan. 7, 2010.
DS00673 Feb. 2, 2010

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Advertisement


Text Size: smaller largerlarger